Plasma osteopontin concentrations in patients with cutaneous melanoma

An effective circulating tumour marker is needed for melanoma especially with the advent of targeted therapies. Gene expression studies examining primary melanomas have shown that increased expression of osteopontin (SPP1) is associated with poor prognosis. Studies subsequently reported higher blood...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: FILIA, A., ELLIOTT, F., WIND, T., FIELD, S., DAVIES, J., KUKALIZCH, K., RANDERSON-MOOR, J., HARLAND, M., BISHOP, D.T., BANKS, R.E., NEWTON-BISHOP, J.A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2013
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3810214/
https://ncbi.nlm.nih.gov/pubmed/23934016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2013.2666
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg